Pacific Biosciences of California, Inc. (PACB) vs Senseonics Holdings, Inc. (SENS)

Pacific Biosciences of California, Inc. and Senseonics Holdings, Inc. are both Medical Devices companies. Senseonics Holdings, Inc. is the larger, with a market value of $546.7M against $484.9M — 1.1× the size. Senseonics Holdings, Inc. grew revenue faster over the last twelve months: 90.6% against 2.02%. Pacific Biosciences of California, Inc. has the higher net margin (−82.5% vs −225.3%) and the higher return on invested capital (−22.2% vs −2,152.1%). Across the 17 metrics below, Pacific Biosciences of California, Inc. leads on 10 and Senseonics Holdings, Inc. on 7.

Valuation

Metric PACB SENS Medical Devices median
P/E n/m n/m 22.18
P/S 3.16 12.00 2.70
P/B n/m 6.45 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 5.72 10.21 2.38
Earnings yield (26.54%) (22.14%) (8.22%)
Free cash flow yield (15.99%) (16.62%) (7.80%)

Profitability

Metric PACB SENS Medical Devices median
Gross margin 36.38% 54.87% 56.01%
Operating margin (83.53%) (223.22%) (15.03%)
Net margin (82.49%) (225.34%) (20.40%)
Free cash flow margin (50.53%) (199.47%) (7.24%)
Return on equity (929.31%) (118.24%) (15.32%)
Return on assets (16.66%) (66.88%) (19.72%)
Return on invested capital (22.22%) (2,152.05%) (10.33%)

Growth

Metric PACB SENS Medical Devices median
Revenue growth (TTM) 2.02% 90.63% 8.80%
EPS growth (last fiscal year) (69.38%) 30.83% —
Revenue growth, 5-year CAGR 15.19% 48.10% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PACB SENS Medical Devices median
Debt to equity (19.40) 0.62 0.07
Current ratio 4.92 6.74 2.50
Net debt to EBITDA (2.33) 0.88 0.49

Dividend

Metric PACB SENS Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric PACB SENS Medical Devices median
Market cap 484.89m 546.72m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack